VKH
CARM

Virtu KCG Holdings’s Carisma Therapeutics CARM Stock Holding History

Virtu KCG Holdings’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$175K Buy
+5,574
New +$186K ﹤0.01% 2222
2017
Q1 		– Sell
-1,474
Closed -$56K – 3164
2016
Q4 		$56K Sell
1,474
-3,425
-70% -$151K ﹤0.01% 3066
2016
Q3 		$274K Buy
4,899
+3,254
+198% +$242K 0.01% 2018
2016
Q2 		$55K Buy
+1,645
New +$41.6K ﹤0.01% 2661
2015
Q4 		– Sell
-1,661
Closed -$80K – 3514
2015
Q3 		$80K Buy
+1,661
New +$102K ﹤0.01% 2889

Other funds holding CARM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's CARM Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Carisma Therapeutics (CARM) in Q2 2017: 5,574 shares worth $175K. The stake represents ﹤0.01% of the portfolio and ranks #2222 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in CARM as recently as Q4 2016.

Virtu KCG Holdings first reported a position in CARM in Q3 2015 and has held it in 5 quarters since. The position peaked at $274K in Q3 2016. 26 funds tracked by Wall St. Rank hold CARM as of Q2 2017.

  • Virtu KCG Holdings held 5,574 shares of Carisma Therapeutics worth $175K as of Q2 2017.
  • Carisma Therapeutics was a new Virtu KCG Holdings position in Q2 2017.
  • Carisma Therapeutics made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2222 holding.
  • Virtu KCG Holdings first reported a position in Carisma Therapeutics in Q3 2015 and has held it in 5 quarters since.
  • Virtu KCG Holdings's Carisma Therapeutics position peaked at $274K in Q3 2016.
  • 26 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.